These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 32487612)

  • 21. Parkinson's disease: assays for the ubiquitin ligase activity of neural Parkin.
    Schlossmacher MG; Shimura H
    Methods Mol Biol; 2005; 301():351-69. PubMed ID: 15917645
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Covalent ISG15 conjugation positively regulates the ubiquitin E3 ligase activity of parkin.
    Im E; Yoo L; Hyun M; Shin WH; Chung KC
    Open Biol; 2016 Aug; 6(8):. PubMed ID: 27534820
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parkin: much more than a simple ubiquitin ligase.
    Alves da Costa C; Checler F
    Neurodegener Dis; 2012; 10(1-4):49-51. PubMed ID: 22204976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
    Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
    Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity.
    Hampe C; Ardila-Osorio H; Fournier M; Brice A; Corti O
    Hum Mol Genet; 2006 Jul; 15(13):2059-75. PubMed ID: 16714300
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interplay between parkin and p53 governs a physiological homeostasis that is disrupted in Parkinson's disease and cerebral cancer.
    Checler F; Alves da Costa C
    Neurodegener Dis; 2014; 13(2-3):118-21. PubMed ID: 24008413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence for a common biological pathway linking three Parkinson's disease-causing genes: parkin, PINK1 and DJ-1.
    van der Merwe C; Jalali Sefid Dashti Z; Christoffels A; Loos B; Bardien S
    Eur J Neurosci; 2015 May; 41(9):1113-25. PubMed ID: 25761903
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nix restores mitophagy and mitochondrial function to protect against PINK1/Parkin-related Parkinson's disease.
    Koentjoro B; Park JS; Sue CM
    Sci Rep; 2017 Mar; 7():44373. PubMed ID: 28281653
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PICK1 inhibits the E3 ubiquitin ligase activity of Parkin and reduces its neuronal protective effect.
    He J; Xia M; Yeung PKK; Li J; Li Z; Chung KK; Chung SK; Xia J
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):E7193-E7201. PubMed ID: 29987020
    [TBL] [Abstract][Full Text] [Related]  

  • 30. N-myc regulates parkin expression.
    West AB; Kapatos G; O'Farrell C; Gonzalez-de-Chavez F; Chiu K; Farrer MJ; Maidment NT
    J Biol Chem; 2004 Jul; 279(28):28896-902. PubMed ID: 15078880
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NAC1, A POZ/BTB protein interacts with Parkin and may contribute to Parkinson's disease.
    Korutla L; Furlong HA; Mackler SA
    Neuroscience; 2014 Jan; 257():86-95. PubMed ID: 24231739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural analysis of the effects of mutations in Ubl domain of Parkin leading to Parkinson's disease.
    Biswas S; Roy R; Biswas R; Bagchi A
    Gene; 2020 Feb; 726():144186. PubMed ID: 31647998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation mechanisms of the E3 ubiquitin ligase parkin.
    Panicker N; Dawson VL; Dawson TM
    Biochem J; 2017 Aug; 474(18):3075-3086. PubMed ID: 28860335
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Common anti-apoptotic roles of parkin and alpha-synuclein in human dopaminergic cells.
    Machida Y; Chiba T; Takayanagi A; Tanaka Y; Asanuma M; Ogawa N; Koyama A; Iwatsubo T; Ito S; Jansen PH; Shimizu N; Tanaka K; Mizuno Y; Hattori N
    Biochem Biophys Res Commun; 2005 Jun; 332(1):233-40. PubMed ID: 15896322
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.
    Shimura H; Schlossmacher MG; Hattori N; Frosch MP; Trockenbacher A; Schneider R; Mizuno Y; Kosik KS; Selkoe DJ
    Science; 2001 Jul; 293(5528):263-9. PubMed ID: 11431533
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Parkin protects against tyrosinase-mediated dopamine neurotoxicity by suppressing stress-activated protein kinase pathways.
    Hasegawa T; Treis A; Patenge N; Fiesel FC; Springer W; Kahle PJ
    J Neurochem; 2008 Jun; 105(5):1700-15. PubMed ID: 18248610
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of differentially regulated deceitful proteins in SH-SY5Y cells engineered with Tet-regulated protein expression system.
    Kanli A; Kasap M; Yoneten KK; Akpinar G; Gulkac MD
    J Cell Biochem; 2018 Jul; 119(7):6065-6071. PubMed ID: 29600520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkin in Parkinson's Disease and Cancer: a Double-Edged Sword.
    Wahabi K; Perwez A; Rizvi MA
    Mol Neurobiol; 2018 Aug; 55(8):6788-6800. PubMed ID: 29349575
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin's effect on neuronal survival.
    Muqit MM; Davidson SM; Payne Smith MD; MacCormac LP; Kahns S; Jensen PH; Wood NW; Latchman DS
    Hum Mol Genet; 2004 Jan; 13(1):117-35. PubMed ID: 14645198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
    Yang H; Zhou X; Liu X; Yang L; Chen Q; Zhao D; Zuo J; Liu W
    Biochem Biophys Res Commun; 2011 Jun; 410(1):114-20. PubMed ID: 21640711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.